Topiramate 25mg – 100 Tablets

Topiramate is an anticonvulsant medication with FDA approval for epilepsy and migraine prevention, and more recently as a component of the combination weight loss medication Qsymia (topiramate/phentermine). This formulation delivers 25mg per tablet in a 100 count format, consistent with the lower starting dose range used across its various clinical indications, including weight management protocols where it is typically titrated gradually.

Topiramate’s mechanism is multifaceted and not fully understood, but it is known to modulate several neurological pathways; enhancing GABA activity, antagonizing certain glutamate receptor subtypes, and inhibiting carbonic anhydrase, among other effects. Its appetite suppressing and weight loss effects, observed as a side effect during its use for seizure and migraine treatment, are thought to be related to its broad central nervous system activity, though the precise mechanism behind its effect on appetite and weight is still being researched. This is why it’s typically combined with phentermine in the FDA approved Qsymia formulation rather than used as a standalone weight loss treatment in most clinical protocols, since the combination has demonstrated a more reliable effect than either compound alone.

Topiramate carries several considerations worth understanding regardless of which indication it’s being used for. Cognitive side effects including word finding difficulty, concentration problems, and memory issues are common enough that the medication has earned the informal nickname “Dopamax” in some clinical communities. It also carries a risk of metabolic acidosis, kidney stones, and significant teratogenic risk (birth defects, including cleft palate) if used during pregnancy, making effective contraception an important consideration for anyone who could become pregnant while taking it. Gradual titration is standard practice both to manage side effects and to reduce withdrawal seizure risk if stopping, since abrupt discontinuation after regular use is not recommended.

Every batch of CSD’s Topiramate is third party lab tested for concentration accuracy and purity before being made available, with COA documentation available on request. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Topiramate is a prescription anticonvulsant medication that should only be used under medical supervision, with particular caution regarding pregnancy risk, cognitive side effects, and the need for gradual dose titration both when starting and stopping. Consult a healthcare provider before use.

Store in a cool, dry place away from direct light and heat.